Tara Pande

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

Timothy R. Abbott, Girija Dhamdhere, Yanxia Liu et al. · Cell · 2020 · 506 citations · Full text

Life Sciences, Biotechnology, Infectious Diseases +14

A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses

Xueqiu Lin, Yanxia Liu, Augustine Chemparathy et al. · Cell Reports Medicine · 2021 · 43 citations · Full text

Life Sciences, Bioinformatics, Infectious Diseases +17

Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza

Timothy R. Abbott, Girija Dhamdhere, Yanxia Liu et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 30 citations

Life Sciences, Infectious Diseases, Molecular Medicine +16

RNA language models predict mutations that improve RNA function

Yekaterina Shulgina, Marena Trinidad, Conner J. Langeberg et al. · Nature Communications · 2024 · 20 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +15

RNA language models predict mutations that improve RNA function

Yekaterina Shulgina, Marena Trinidad, Conner J. Langeberg et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 11 citations · Full text

Life Sciences, Bioinformatics, Biology +15